🔎 Trials Near Me

Hjem › Alvorlig depressiv lidelse › Florida › Orlando

Alvorlig depressiv lidelse kliniske forsøg i Orlando, FL

19 studier for Alvorlig depressiv lidelse søger deltagere på steder i og omkring Orlando (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

RekruttererFase 3
  • Nova Psychiatry INC, Orlando
Alder 18 til 74 · Alle køn · Opdateret 25. sep. 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

RekruttererFase 2
  • Clinical Neuroscience Solutions Inc. - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi væk
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

RekruttererFase 3
  • Accel Research Sites - Maitland, Maitland · 6 mi væk
Alder 18 til 85 · Alle køn · Opdateret 25. sep. 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

RekruttererFase 2
  • Seaport Investigator Site, Orlando
Alder 18 til 65 · Alle køn · Opdateret 14. sep. 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

RekruttererFase 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Alder 18 til 65 · Alle køn · Opdateret 14. sep. 2026 · NCT07284667

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

RekruttererFase 2
  • Draig Clinical Site, Orlando
  • Draig Clinical Site, Orlando
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

RekruttererFase 2
  • Draig Clinical Site, Orlando
Alder 18 til 75 · Alle køn · Opdateret 26. aug. 2026 · NCT07300969

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

RekruttererFase 3
  • Clinical Neuroscience Solutions, LLC (Orlando), Orlando
  • Charter Research, Orlando
  • K2 Medical Research (Maitland), Maitland · 6 mi væk
Alder 18 til 74 · Alle køn · Opdateret 10. aug. 2026 · NCT07592689

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Maitland · 6 mi væk
Alder 18 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

RekruttererFase 3
  • Charter Research - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi væk
Alder 18 til 75 · Alle køn · Opdateret 6. aug. 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

RekruttererFase 3
  • Clinical Neuroscience Solutions, Inc., Orlando
Alder 18 til 74 · Alle køn · Opdateret 3. aug. 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

RekruttererFase 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Alder 18 til 64 · Alle køn · Opdateret 3. aug. 2026 · NCT06547489

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Orlando
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Maitland · 6 mi væk
  • Neurocrine Clinical Site, Maitland · 6 mi væk
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

RekruttererFase 2
  • Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando
Alder 18 til 65 · Alle køn · Opdateret 15. jun. 2026 · NCT07276997

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Maitland · 6 mi væk
Alder 18 og opefter · Alle køn · Opdateret 29. okt. 2025 · NCT06786624

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

Rekrutterer
  • AdventHealth Neuroscience Institute, Orlando
Alder 60 og opefter · Alle køn · Opdateret 22. okt. 2025 · NCT05877885

Study of ALTO-300 in MDD

RekruttererFase 2
  • Site 159, Clermont · 24 mi væk
Alder 18 til 70 · Alle køn · Opdateret 24. jul. 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

RekruttererFase 4
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
Alder 18 til 65 · Alle køn · Opdateret 23. jan. 2025 · NCT06223880

Alvorlig depressiv lidelse forsøg i andre byer

Andre studier i Orlando

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.